Edaravone clinical trials

Studies by the year they started

36 studies that test it; most in 2021 (6)

Who runs them

Industry 20 · Other 16

Shionogi (18) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2) · Shanghai Auzone Biological Technology Co., Ltd. (1) · Hui-Sheng Chen (1) · Nanjing Yoko Biomedical Co., Ltd. (1) · Kumamoto University (1) · Combination Therapy for Acute Ischemic Stroke Study Group (1) · Yi Yang (1)

Often tested with

Tested in the same studies.

Dexborneol (7) · Taurine (1) · Nerve Growth Factor (1) · Scopolamine (1) · Atropine (1) · Dexmedetomidine (1) · Urinastatin (1) · Tranexamic Acid (1)

Studies

Open first, then newest update. How each study uses Edaravone is read from its arms, and is right about nine times in ten.

Testing it · 36

• Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment StudyRecruitingPhase 4Chuansheng ZhaoNCT07454473Written as Edaravone Dexborneol
• Edaravone in the Treatment of Optic NeuritisRecruitingNot applicableFirst Affiliated Hospital of Guangxi Medical UniversityNCT05540262Written as Edaravone
• Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic StrokeNot yet recruitingPhase 4Yi YangNCT06645522Written as Edaravone dexborneol
• Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone DexborneolRecruitingPhase 4The Second Hospital of Hebei Medical UniversityNCT06248242Written as Edaravone dexborneol
• Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic StrokeCompletedPhase 4ShionogiNCT00200356Written as Edaravone
• Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral SclerosisCompletedPhase 3ShionogiNCT01492686Written as MCI-186
• Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)CompletedPhase 3ShionogiNCT00330681Written as MCI-186
• Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification IIICompletedPhase 3ShionogiNCT00415519Written as MCI-186
• Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedPhase 3ShionogiNCT00424463Written as MCI-186
• Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALSCompletedPhase 3ShionogiNCT05568615Written as MT-1186
• Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With GastrostomyCompletedPhase 1ShionogiNCT04254913Written as MT-1186
• Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic StrokeCompletedPhase 2ShionogiNCT00821821Written as MCI-186
• Study of Oral Edaravone in Healthy Adult MalesCompletedPhase 1ShionogiNCT04481750Written as MT-1186
• PK Study in Subjects With Severe Hepatic ImpairmentCompletedPhase 1ShionogiNCT03664544Written as MCI-186
• Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)CompletedPhase 1ShionogiNCT04481789Written as MT-1186
• Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric TubeCompletedPhase 1ShionogiNCT04776135Written as MT-1186
• Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral SclerosisCompletedPhase 1ShionogiNCT04176224Written as MT-1186
• Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult SubjectsCompletedPhase 1ShionogiNCT04493281Written as MT-1186
• Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic ImpairmentCompletedPhase 1ShionogiNCT03289234Written as MCI-186
• Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal ImpairmentCompletedPhase 1ShionogiNCT03289208Written as MCI-186

See all 36 studies that test Edaravone →

Codes

What other systems call Edaravone · ClinicalTrials.gg INT006749

• MeSH (NLM) D000077553EdaravoneConfirmed ClinicalTrials.gov, NLM, Wikidata
• UNII (FDA) S798V6YJRPEDARAVONEConfirmed FDA, NLM, Wikidata
• RxNorm 1921877Confirmed FDA, Wikidata
• Wikidata Q335099edaravoneConfirmed FDA, NLM, Wikidata
• NCI Thesaurus C74323EdaravoneConfirmed FDA, Wikidata
• DrugBank DB12243One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.